Patents by Inventor Maud Bongaerts

Maud Bongaerts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Sterile Emulsion Comprising a Stable Phosphorothioate Oligonucleotide
    Publication number: 20170035693
    Abstract: The present invention relates to a composition comprising a phosphorothioate oligonucleotide and at least one fatty acid and/or at least one emulsifying agent, wherein said composition is sterile and wherein said composition comprises an agent comprising a thiol group, preferably said composition is an ophthalmic composition; to a method for obtaining the same and to the therapeutic use thereof.
    Type: Application
    Filed: August 7, 2015
    Publication date: February 9, 2017
    Applicant: GENE SIGNAL INTERNATIONAL SA
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Celine Steverlynck
  • Inhibitor of IRS-1 for treating skin disorders
    Patent number: 9359604
    Abstract: The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease.
    Type: Grant
    Filed: July 3, 2012
    Date of Patent: June 7, 2016
    Assignee: GENE SIGNAL INTERNATIONAL SA
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Cèline Steverlynck, Jean-Pascal Conduzorgues, Amel Hadri, Eric Viaud
  • USE OF AN INHIBITOR OF IRS-1 FOR TREATING SKIN DISORDERS
    Publication number: 20150283165
    Abstract: The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease.
    Type: Application
    Filed: July 3, 2013
    Publication date: October 8, 2015
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Celine Steverlynck, Jean-Pascal Conduzorgues, Amel Hadri, Eric Viaud
  • Inhibitor of IRS-1 for Treating Skin Disorders
    Publication number: 20140011858
    Abstract: The present invention relates to an inhibitor of the expression of IRS-1 for treating an angiogenic and/or inflammatory skin disease. The present invention also relates to a transdermal composition, preferably an ointment, comprising an inhibitor of the expression of IRS-1, and to the use thereof for treating an angiogenic and/or inflammatory skin disease.
    Type: Application
    Filed: July 3, 2012
    Publication date: January 9, 2014
    Inventors: Salman Al-Mahmood, Sylvie Colin, Maud Bongaerts, Cèline Steverlynck, Jean-Pascal Conduzorgues, Amel Hadri, Eric Viaud